Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS

Table of Contents

March 01, 2004; Volume 31,Issue 3
  • You have access
    Clinical trials, outcome measures, and response criteria.
    Stanley R Pillemer and Barbara Tilley
    The Journal of Rheumatology March 1 2004, 31 (3) 407-410;
  • You have access
    Defining therapeutic success in rheumatoid arthritis clinical trials: from statistical significance to clinical significance.
    Andreas Maetzel
    The Journal of Rheumatology March 1 2004, 31 (3) 411-412;
  • You have access
    Suboptimal osteoporosis management: moving beyond detection.
    Tuhina Neogi and Jeroan J Allison
    The Journal of Rheumatology March 1 2004, 31 (3) 413-415;
  • You have access
    Hepatitis C and B cells: induction of autoimmunity and lymphoproliferation may reflect chronic stimulation through cell-surface receptors.
    Gordon Starkebaum and Eric H Sasso
    The Journal of Rheumatology March 1 2004, 31 (3) 416-418;
  • You have access
    Estrogen metabolites: increasing evidence for their role in rheumatoid arthritis and systemic lupus erythematosus.
    Maurizio Cutolo
    The Journal of Rheumatology March 1 2004, 31 (3) 419-421;
  • You have access
    Polymorphism in promoter region of IL10 gene is associated with rheumatoid arthritis in women.
    Leonid Padyukov, Ann-Marie Hytönen, Marina Smolnikova, Mirjana Hahn-Zoric, Nicklas Nilsson, Lars-Ake Hanson, Andrej Tarkowski and Lars Klareskog
    The Journal of Rheumatology March 1 2004, 31 (3) 422-425;
  • You have access
    Tumor necrosis factor-alpha promotes the expression of osteoprotegerin in rheumatoid synovial fibroblasts.
    Ayako Kubota, Kazuhisa Hasegawa, Toru Suguro and Yasuko Koshihara
    The Journal of Rheumatology March 1 2004, 31 (3) 426-435;
  • You have access
    Erythromycin suppresses the expression of cyclooxygenase-2 in rheumatoid synovial cells.
    Takehide Fumimori, Seiyo Honda, Kiyoshi Migita, Minako Hamada, Taro Yoshimuta, Junichi Honda, Takaaki Fukuda, Ritsu Suzuki, Masafumi Gotoh, Katsumi Eguchi and Hisamichi Aizawa
    The Journal of Rheumatology March 1 2004, 31 (3) 436-441;
  • You have access
    Polymorphisms in the mannose binding lectin (MBL) gene are not associated with radiographic erosions in rheumatoid or inflammatory polyarthritis.
    Anne Barton, Hazel Platt, Fiona Salway, Deborah Symmons, Mark Lunt, Jane Worthington and Alan Silman
    The Journal of Rheumatology March 1 2004, 31 (3) 442-447;
  • You have access
    Expression of interleukin 12 receptor (IL-12R) and IL-18R on CD4+ T cells from patients with rheumatoid arthritis.
    Tetsushi Aita, Masahiro Yamamura, Masanori Kawashima, Akira Okamoto, Mitsuhiro Iwahashi, Jiro Yamana and Hirofumi Makino
    The Journal of Rheumatology March 1 2004, 31 (3) 448-456;
  • You have access
    Immune activation and depression in women with rheumatoid arthritis.
    Alex J Zautra, David C Yocum, Isidro Villanueva, Bruce Smith, Mary C Davis, Jeanne Attrep and Michael Irwin
    The Journal of Rheumatology March 1 2004, 31 (3) 457-463;
  • You have access
    Role of mRNA expression of transcription factors in glucocorticoid sensitivity of peripheral blood mononuclear cells and disease state in rheumatoid arthritis.
    Kenji Onda, Emiko Rimbara, Toshihiko Hirano, Kitaro Oka, Haruo Abe, Koichiro Tahara, Hirofumi Takanashi, Norioki Tsuboi, Tomoyuki Niitsuma and Tohru Hayashi
    The Journal of Rheumatology March 1 2004, 31 (3) 464-469;
  • You have access
    Patient retention and hand-wrist radiograph progression of rheumatoid arthritis during a 3-year prospective study that prohibited disease modifying antirheumatic drugs.
    Harold E Paulus, Daniel Di Primeo, John T Sharp, Harry K Genant, Barbara N Weissman, Michael H Weisman, Marie Sanda and Long-Term Etodolac Study Investigators
    The Journal of Rheumatology March 1 2004, 31 (3) 470-481;
  • You have access
    Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR.
    John A Snowden, Jakob Passweg, John J Moore, Sam Milliken, Paul Cannell, Jacob Van Laar, Robert Verburg, Jeffrey Szer, Kerry Taylor, David Joske, Simon Rule, Sarah J Bingham, Paul Emery, Richard K Burt, Raymond M Lowenthal, Patrick Durez, Robert J McKendry, Steven Z Pavletic, Ildefonso Espigado, Esa Jantunen, Ashwin Kashyap, Marco Rabusin, Peter Brooks, Christopher Bredeson and Alan Tyndall
    The Journal of Rheumatology March 1 2004, 31 (3) 482-488;
  • You have access
    Patients with rheumatoid arthritis and systemic lupus erythematosus have increased renal excretion of mitogenic estrogens in relation to endogenous antiestrogens.
    Claudia Weidler, Peter Härle, Joerg Schedel, Martin Schmidt, Jürgen Schölmerich and Rainer H Straub
    The Journal of Rheumatology March 1 2004, 31 (3) 489-494;
  • You have access
    Triple association between hepatitis C virus infection, systemic autoimmune diseases, and B cell lymphoma.
    Manuel Ramos-Casals, Olga Trejo, Mario García-Carrasco, Ricard Cervera, Gloria De La Red, Victor Gil, Armando López-Guillermo, Miguel Ingelmo and Josep Font
    The Journal of Rheumatology March 1 2004, 31 (3) 495-499;
  • You have access
    Autoantibodies against alpha-fodrin in Sjögren's syndrome with neurological manifestations.
    Jérôme de Seze, Sylvain Dubucquoi, Anne-Laure Fauchais, Eric Hachulla, Torsten Matthias, Didier Lefranc, Pierre-Yves Hatron, Patrick Vermersch and Torsten Witte
    The Journal of Rheumatology March 1 2004, 31 (3) 500-503;
  • You have access
    Sensitivity and specificity for primary Sjögren's syndrome of IgA and IgG anti-alpha-fodrin antibodies detected by ELISA.
    Amelia Ruffatti, Pierantonio Ostuni, Panagiotis Grypiotis, Costantino Botsios, Marta Tonello, Chiara Grava, Maria Favaro and Silvano Todesco
    The Journal of Rheumatology March 1 2004, 31 (3) 504-507;
  • You have access
    Erectile dysfunction associated with scleroderma: a case-control study of men with scleroderma and rheumatoid arthritis.
    Paul Hong, Janet E Pope, Janine M Ouimet, Eugenia Rullan and James R Seibold
    The Journal of Rheumatology March 1 2004, 31 (3) 508-513;
  • You have access
    Elevated circulating CD40L concentrations in patients with systemic sclerosis.
    Kazuhiro Komura, Shinichi Sato, Minoru Hasegawa, Manabu Fujimoto and Kazuhiko Takehara
    The Journal of Rheumatology March 1 2004, 31 (3) 514-519;
  • You have access
    Geographical and genetic factors do not account for significant differences in the clinical spectrum of giant cell arteritis in southern europe.
    Miguel A Gonzalez-Gay, Luigi Boiardi, Carlos Garcia-Porrua, Pierluigi Macchioni, Juan C Amor-Dorado and Carlo Salvarani
    The Journal of Rheumatology March 1 2004, 31 (3) 520-523;
  • You have access
    Uveitis as the initial clinical manifestation in patients with spondyloarthropathies.
    Julia Fernández-Melón, Santiago Muñoz-Fernández, Ventura Hidalgo, Gema Bonilla-Hernán, Armel Schlincker, Antonio Fonseca, José Vieitez and Emilio Martín-Mola
    The Journal of Rheumatology March 1 2004, 31 (3) 524-527;
  • You have access
    Reactive arthritis following an outbreak of Campylobacter jejuni infection.
    Timo Hannu, Markku Kauppi, Marja Tuomala, Irja Laaksonen, Peter Klemets and Markku Kuusi
    The Journal of Rheumatology March 1 2004, 31 (3) 528-530;
  • You have access
    Successful short term treatment of patients with severe undifferentiated spondyloarthritis with the anti-tumor necrosis factor-alpha fusion receptor protein etanercept.
    Jan Brandt, Andre Khariouzov, Joachim Listing, Hildrun Haibel, Helmut Sörensen, Martin Rudwaleit, Joachim Sieper and Jurgen Braun
    The Journal of Rheumatology March 1 2004, 31 (3) 531-538;
  • You have access
    A portable digital microphotography unit for rapid documentation of periungual nailfold capillary changes in autoimmune connective tissue diseases.
    Richard D Sontheimer
    The Journal of Rheumatology March 1 2004, 31 (3) 539-544;
  • You have access
    The cervical spine in calcium pyrophosphate dihydrate deposition disease. A prevalent case-control study.
    Axel Finckh, Daniel Van Linthoudt, Bertrand Duvoisin, Philippe Bovay and Jean-Charles Gerster
    The Journal of Rheumatology March 1 2004, 31 (3) 545-549;
  • You have access
    Multifaceted educational program increases prescribing of preventive medication for corticosteroid induced osteoporosis.
    Mark Naunton, Gregory M Peterson, Graeme Jones, Gillian M Griffin and Martin D Bleasel
    The Journal of Rheumatology March 1 2004, 31 (3) 550-556;
  • You have access
    Lubricating ability of aspirated synovial fluid from emergency department patients with knee joint synovitis.
    Gregory D Jay, Khaled A Elsaid, Jeffrey Zack, Kristine Robinson, Flor Trespalacios, Chung-Ja Cha and Clinton O Chichester
    The Journal of Rheumatology March 1 2004, 31 (3) 557-564;
  • You have access
    Efficacy and safety of 5% ibuprofen cream treatment in knee osteoarthritis. Results of a randomized, double-blind, placebo-controlled study.
    Karel Trnavský, Michael Fischer, Ute Vögtle-Junkert and Frank Schreyger
    The Journal of Rheumatology March 1 2004, 31 (3) 565-572;
  • You have access
    Hospital, pharmacy, and outpatient costs for osteoarthritis and chronic back pain.
    Douglas W Mapel, Michael Shainline, Kathy Paez and Margaret Gunter
    The Journal of Rheumatology March 1 2004, 31 (3) 573-583;
  • You have access
    Lyon Schuss radiographic view of the knee. Utility of fluoroscopy for the quality of tibial plateau alignment.
    Thierry Conrozier, Pierre Mathieu, Muriel Piperno, Diego Provvedini, Alain Taccoen, Frederic Colson, Jean-Pierre Duivon, Robert Dusan, Huguette Favret and Eric Vignon
    The Journal of Rheumatology March 1 2004, 31 (3) 584-590;
  • You have access
    Are preferences for cyclooxygenase-2 inhibitors influenced by the certainty effect?
    Liana Fraenkel, Dick R Wittink, John Concato and Terri Fried
    The Journal of Rheumatology March 1 2004, 31 (3) 591-593;
  • You have access
    Prevalence of rheumatic diseases in Brazil: a study using the COPCORD approach.
    Erika Rodrigues Senna, Ana Letícia P De Barros, Edvânia O Silva, Isabella F Costa, Leonardo Victor B Pereira, Rozana Mesquita Ciconelli and Marcos Bosi Ferraz
    The Journal of Rheumatology March 1 2004, 31 (3) 594-597;
  • You have access
    Clues to pathogenesis of fibromyalgia in patients with sickle cell disease.
    Naomi Schlesinger
    The Journal of Rheumatology March 1 2004, 31 (3) 598-600;
  • You have access
    MHC Class I overexpression on muscles in early juvenile dermatomyositis.
    Charles K C Li, Hemlata Varsani, Janice L Holton, Bin Gao, Patricia Woo, Lucy R Wedderburn and Juvenile Dermatomyositis Research Group (UK and Ireland)
    The Journal of Rheumatology March 1 2004, 31 (3) 605-609;
  • You have access
    Decreased pain threshold in children with growing pains.
    Philip J Hashkes, Orit Friedland, Lutfi Jaber, Herman A Cohen, Baruch Wolach and Yosef Uziel
    The Journal of Rheumatology March 1 2004, 31 (3) 610-613;
  • You have access
    Circulating vascular endothelial growth factor concentrations in a case of pulmonary hypertrophic osteoarthropathy. Correlation with disease activity.
    Francisco Olán, Margarita Portela, Carmen Navarro, Miguel Gaxiola, Luis H Silveira, Victor Ruiz and Manuel Martínez-Lavín
    The Journal of Rheumatology March 1 2004, 31 (3) 614-616;
  • You have access
    Unusual differential diagnosis of a swollen toe.
    Matthias Wahle and Christoph G O Baerwald
    The Journal of Rheumatology March 1 2004, 31 (3) 617-619;
  • You have access
    Diffuse idiopathic skeletal hyperostosis: isolated involvement of cervical spine in a young patient.
    Reuven Mader
    The Journal of Rheumatology March 1 2004, 31 (3) 620-621;
  • You have access
    Arthritis induced by corticosteroid crystals.
    Enrico Selvi, Renato De Stefano, Sauro Lorenzini and Roberto Marcolongo
    The Journal of Rheumatology March 1 2004, 31 (3) 622;
  • You have access
    Macrophage activation syndrome and etanercept in children with systemic juvenile rheumatoid arthritis.
    Haroon Sawar, Luis R Espinoza and Abraham Gedalia
    The Journal of Rheumatology March 1 2004, 31 (3) 623;
  • You have access
    Therapeutic implications for interferon-alpha in arthritis.
    Ina Kötter and Nicole Stübiger
    The Journal of Rheumatology March 1 2004, 31 (3) 624-625;
  • You have access
    False positive parvovirus serology.
    Alice H Johnson and Andrew Gough
    The Journal of Rheumatology March 1 2004, 31 (3) 625-626;
Back to top
PreviousNext

In this issue

The Journal of Rheumatology
Vol. 31, Issue 3
1 Mar 2004
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Most Read
  • ​ Editor's Picks
  • E-letters
Loading
  • Effects of Bedtime Very Low Dose Cyclobenzaprine on Symptoms and Sleep Physiology in Patients with Fibromyalgia Syndrome: A Double-blind Randomized Placebo-controlled Study
  • Nail Psoriasis: Diagnosis, Assessment, Treatment Options, and Unmet Clinical Needs
  • Optic Perineuritis as the Initial Presentation of Syphilis in a Patient on Biologics
  • Rheumatoid Arthritis or Imitator?
  • An Overview of Reviews to Inform Organization-Level Interventions to Address Burnout in Rheumatologists
More...

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2023 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire